Scott H. Schelling
Pfizer (United States)(US)
Publications by Year
Research Areas
Veterinary Oncology Research, Virus-based gene therapy research, Sarcoma Diagnosis and Treatment, Ovarian cancer diagnosis and treatment, Cell Adhesion Molecules Research
Most-Cited Works
- → Healing Segmental Femoral Defects in Sheep Using Recombinant Human Bone Morphogenetic Protein(1993)309 cited
- → Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988)(1992)309 cited
- → Double‐knockout of ADAMTS‐4 and ADAMTS‐5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis(2007)214 cited
- → IL-22 Induces an Acute-Phase Response(2010)172 cited
- → Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991–1992)(1994)169 cited
- → Canine Leptospirosis: A Retrospective Study of 17 Cases(1992)149 cited
- → Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990)(1992)125 cited
- → Healing Bone Using Recombinant Human Bone Morphogenetic Protein 2 and Copolymer(1998)102 cited
- → Selective functional inhibition of JAK‐3 is sufficient for efficacy in collagen‐induced arthritis in mice(2010)74 cited
- → Neurovisceral and Skeletal G M1 -Gangliosidosis in Dogs with β-Galactosidase Deficiency(1985)52 cited